Canton Strategic Holdings Inc CNTN
News
Canton Strategic Holdings, Inc. Releases Second Quarter 2026 Financial and Operational Results
Three New Directors Elected to the Board of Canton Strategic Holdings, Inc.
Canton Strategic Holdings, Inc. Announces Sale of Gravitas Life Sciences, LLC
Tharimmune Shares Drop Premarket Following FDA Feedback on Plan for Lead Clinical Asset
Tharimmune Shares Rise After $540 Million Private Placement

